Simultaneous  ||| S:0 E:13 ||| JJ
multi-depth  ||| S:13 E:25 ||| JJ
assessment  ||| S:25 E:36 ||| NN
of  ||| S:36 E:39 ||| IN
tissue  ||| S:39 E:46 ||| NN
oxygen  ||| S:46 E:53 ||| NN
saturation  ||| S:53 E:64 ||| NN
in  ||| S:64 E:67 ||| IN
thenar  ||| S:67 E:74 ||| NN
and  ||| S:74 E:78 ||| CC
forearm  ||| S:78 E:86 ||| VBP
using  ||| S:86 E:92 ||| VBG
near-infrared  ||| S:92 E:106 ||| JJ
spectroscopy  ||| S:106 E:119 ||| NN
during  ||| S:119 E:126 ||| IN
a  ||| S:126 E:128 ||| DT
simple  ||| S:128 E:135 ||| JJ
cardiovascular  ||| S:135 E:150 ||| JJ
challenge  ||| S:150 E:160 ||| NN
Hypovolemia  ||| S:160 E:172 ||| NNP
and  ||| S:172 E:176 ||| CC
hypovolemic  ||| S:176 E:188 ||| JJ
shock  ||| S:188 E:194 ||| NN
are  ||| S:194 E:198 ||| VBP
life-threatening  ||| S:198 E:215 ||| JJ
conditions  ||| S:215 E:226 ||| NNS
that  ||| S:226 E:231 ||| WDT
occur  ||| S:231 E:237 ||| VBP
in  ||| S:237 E:240 ||| IN
numerous  ||| S:240 E:249 ||| JJ
clinical  ||| S:249 E:258 ||| JJ
scenarios ||| S:258 E:267 ||| NNS
.  ||| S:267 E:269 ||| .
Near-infrared  ||| S:269 E:283 ||| JJ
spectroscopy  ||| S:283 E:296 ||| NNS
( ||| S:296 E:297 ||| -LRB-
NIRS ||| S:297 E:301 ||| NNP
)  ||| S:301 E:303 ||| -RRB-
has  ||| S:303 E:307 ||| VBZ
been  ||| S:307 E:312 ||| VBN
widely  ||| S:312 E:319 ||| RB
explored ||| S:319 E:327 ||| JJ
,  ||| S:327 E:329 ||| ,
successfully  ||| S:329 E:342 ||| RB
and  ||| S:342 E:346 ||| CC
unsuccessfully ||| S:346 E:360 ||| RB
,  ||| S:360 E:362 ||| ,
in  ||| S:362 E:365 ||| IN
an  ||| S:365 E:368 ||| DT
attempt  ||| S:368 E:376 ||| NN
to  ||| S:376 E:379 ||| TO
use  ||| S:379 E:383 ||| VB
it  ||| S:383 E:386 ||| PRP
as  ||| S:386 E:389 ||| IN
an  ||| S:389 E:392 ||| DT
early  ||| S:392 E:398 ||| JJ
detector  ||| S:398 E:407 ||| NN
of  ||| S:407 E:410 ||| IN
hypovolemia  ||| S:410 E:422 ||| NN
by  ||| S:422 E:425 ||| IN
measuring  ||| S:425 E:435 ||| VBG
tissue  ||| S:435 E:442 ||| NN
oxygen  ||| S:442 E:449 ||| NN
saturation  ||| S:449 E:460 ||| NNS
( ||| S:460 E:461 ||| -LRB-
StO2 ||| S:461 E:465 ||| NNP
) ||| S:465 E:466 ||| -RRB-
.  ||| S:466 E:468 ||| .
In  ||| S:468 E:471 ||| IN
order  ||| S:471 E:477 ||| NN
to  ||| S:477 E:480 ||| TO
investigate  ||| S:480 E:492 ||| VB
the  ||| S:492 E:496 ||| DT
measurement  ||| S:496 E:508 ||| NN
site  ||| S:508 E:513 ||| NN
dependence  ||| S:513 E:524 ||| NN
and  ||| S:524 E:528 ||| CC
probe  ||| S:528 E:534 ||| NN
dependence  ||| S:534 E:545 ||| NN
of  ||| S:545 E:548 ||| IN
NIRS  ||| S:548 E:553 ||| NNP
in  ||| S:553 E:556 ||| IN
response  ||| S:556 E:565 ||| NN
to  ||| S:565 E:568 ||| TO
hemodynamic  ||| S:568 E:580 ||| VB
changes ||| S:580 E:587 ||| NNS
,  ||| S:587 E:589 ||| ,
such  ||| S:589 E:594 ||| JJ
as  ||| S:594 E:597 ||| IN
hypovolemia ||| S:597 E:608 ||| NN
,  ||| S:608 E:610 ||| ,
we  ||| S:610 E:613 ||| PRP
applied  ||| S:613 E:621 ||| VBD
a  ||| S:621 E:623 ||| DT
simple  ||| S:623 E:630 ||| JJ
cardiovascular  ||| S:630 E:645 ||| JJ
challenge ||| S:645 E:654 ||| NN
:  ||| S:654 E:656 ||| :
a  ||| S:656 E:658 ||| DT
posture  ||| S:658 E:666 ||| NN
change  ||| S:666 E:673 ||| NN
from  ||| S:673 E:678 ||| IN
supine  ||| S:678 E:685 ||| VBG
to  ||| S:685 E:688 ||| TO
upright ||| S:688 E:695 ||| VB
,  ||| S:695 E:697 ||| ,
causing  ||| S:697 E:705 ||| VBG
a  ||| S:705 E:707 ||| DT
decrease  ||| S:707 E:716 ||| NN
in  ||| S:716 E:719 ||| IN
stroke  ||| S:719 E:726 ||| JJ
volume  ||| S:726 E:733 ||| NN
( ||| S:733 E:734 ||| -LRB-
as  ||| S:734 E:737 ||| RB
in  ||| S:737 E:740 ||| IN
hypovolemia ||| S:740 E:751 ||| CD
)  ||| S:751 E:753 ||| -RRB-
and  ||| S:753 E:757 ||| CC
a  ||| S:757 E:759 ||| DT
heart  ||| S:759 E:765 ||| NN
rate  ||| S:765 E:770 ||| NN
increase  ||| S:770 E:779 ||| NN
in  ||| S:779 E:782 ||| IN
combination  ||| S:782 E:794 ||| NN
with  ||| S:794 E:799 ||| IN
peripheral  ||| S:799 E:810 ||| JJ
vasoconstriction  ||| S:810 E:827 ||| NN
to  ||| S:827 E:830 ||| TO
maintain  ||| S:830 E:839 ||| VB
adequate  ||| S:839 E:848 ||| JJ
blood  ||| S:848 E:854 ||| NN
pressure ||| S:854 E:862 ||| NN
.  ||| S:862 E:864 ||| .
Multi-depth  ||| S:864 E:876 ||| NNP
NIRS  ||| S:876 E:881 ||| NNP
was  ||| S:881 E:885 ||| VBD
used  ||| S:885 E:890 ||| VBN
in  ||| S:890 E:893 ||| IN
nine  ||| S:893 E:898 ||| CD
healthy  ||| S:898 E:906 ||| JJ
volunteers  ||| S:906 E:917 ||| NNS
to  ||| S:917 E:920 ||| TO
assess  ||| S:920 E:927 ||| VB
changes  ||| S:927 E:935 ||| NNS
in  ||| S:935 E:938 ||| IN
StO2  ||| S:938 E:943 ||| CD
in  ||| S:943 E:946 ||| IN
the  ||| S:946 E:950 ||| DT
thenar  ||| S:950 E:957 ||| NN
and  ||| S:957 E:961 ||| CC
forearm  ||| S:961 E:969 ||| NN
in  ||| S:969 E:972 ||| IN
response  ||| S:972 E:981 ||| NN
to  ||| S:981 E:984 ||| TO
the  ||| S:984 E:988 ||| DT
hemodynamic  ||| S:988 E:1000 ||| JJ
changes  ||| S:1000 E:1008 ||| NNS
associated  ||| S:1008 E:1019 ||| VBN
with  ||| S:1019 E:1024 ||| IN
a  ||| S:1024 E:1026 ||| DT
posture  ||| S:1026 E:1034 ||| NN
change  ||| S:1034 E:1041 ||| NN
from  ||| S:1041 E:1046 ||| IN
supine  ||| S:1046 E:1053 ||| VBG
to  ||| S:1053 E:1056 ||| TO
upright ||| S:1056 E:1063 ||| VB
.  ||| S:1063 E:1065 ||| .
A  ||| S:1065 E:1067 ||| DT
posture  ||| S:1067 E:1075 ||| NN
change  ||| S:1075 E:1082 ||| NN
from  ||| S:1082 E:1087 ||| IN
supine  ||| S:1087 E:1094 ||| VBG
to  ||| S:1094 E:1097 ||| TO
upright  ||| S:1097 E:1105 ||| VB
resulted  ||| S:1105 E:1114 ||| VBN
in  ||| S:1114 E:1117 ||| IN
a  ||| S:1117 E:1119 ||| DT
significant  ||| S:1119 E:1131 ||| JJ
increase  ||| S:1131 E:1140 ||| NN
( ||| S:1140 E:1141 ||| -LRB-
P  ||| S:1141 E:1143 ||| NNP
< ||| S:1143 E:1145 ||| SYM
0.001 ||| S:1145 E:1150 ||| NNP
)  ||| S:1150 E:1152 ||| -RRB-
in  ||| S:1152 E:1155 ||| IN
heart  ||| S:1155 E:1161 ||| NN
rate ||| S:1161 E:1165 ||| NN
.  ||| S:1165 E:1167 ||| .
Thenar  ||| S:1167 E:1174 ||| NNP
StO2  ||| S:1174 E:1179 ||| NNP
did  ||| S:1179 E:1183 ||| VBD
not  ||| S:1183 E:1187 ||| RB
respond  ||| S:1187 E:1195 ||| VB
to  ||| S:1195 E:1198 ||| TO
the  ||| S:1198 E:1202 ||| DT
hemodynamic  ||| S:1202 E:1214 ||| JJ
changes  ||| S:1214 E:1222 ||| NNS
following  ||| S:1222 E:1232 ||| VBG
the  ||| S:1232 E:1236 ||| DT
posture  ||| S:1236 E:1244 ||| NN
change ||| S:1244 E:1250 ||| NN
,  ||| S:1250 E:1252 ||| ,
whereas  ||| S:1252 E:1260 ||| IN
forearm  ||| S:1260 E:1268 ||| JJ
StO2  ||| S:1268 E:1273 ||| NN
did ||| S:1273 E:1276 ||| VBD
.  ||| S:1276 E:1278 ||| .
Forearm  ||| S:1278 E:1286 ||| NNP
StO2  ||| S:1286 E:1291 ||| NNP
was  ||| S:1291 E:1295 ||| VBD
significantly  ||| S:1295 E:1309 ||| RB
lower  ||| S:1309 E:1315 ||| JJR
( ||| S:1315 E:1316 ||| -LRB-
P  ||| S:1316 E:1318 ||| NNP
< ||| S:1318 E:1320 ||| SYM
0.001 ||| S:1320 E:1325 ||| NNP
)  ||| S:1325 E:1327 ||| -RRB-
in  ||| S:1327 E:1330 ||| IN
the  ||| S:1330 E:1334 ||| DT
upright  ||| S:1334 E:1342 ||| JJ
position  ||| S:1342 E:1351 ||| NN
compared  ||| S:1351 E:1360 ||| VBN
to  ||| S:1360 E:1363 ||| TO
supine  ||| S:1363 E:1370 ||| VB
for  ||| S:1370 E:1374 ||| IN
all  ||| S:1374 E:1378 ||| DT
probing  ||| S:1378 E:1386 ||| JJ
depths ||| S:1386 E:1392 ||| NNS
.  ||| S:1392 E:1394 ||| .
The  ||| S:1394 E:1398 ||| DT
primary  ||| S:1398 E:1406 ||| JJ
findings  ||| S:1406 E:1415 ||| NNS
in  ||| S:1415 E:1418 ||| IN
this  ||| S:1418 E:1423 ||| DT
study  ||| S:1423 E:1429 ||| NN
were  ||| S:1429 E:1434 ||| VBD
that  ||| S:1434 E:1439 ||| DT
forearm  ||| S:1439 E:1447 ||| JJ
StO2  ||| S:1447 E:1452 ||| NN
is  ||| S:1452 E:1455 ||| VBZ
a  ||| S:1455 E:1457 ||| DT
more  ||| S:1457 E:1462 ||| RBR
sensitive  ||| S:1462 E:1472 ||| JJ
parameter  ||| S:1472 E:1482 ||| NN
to  ||| S:1482 E:1485 ||| TO
hemodynamic  ||| S:1485 E:1497 ||| VB
changes  ||| S:1497 E:1505 ||| NNS
than  ||| S:1505 E:1510 ||| IN
thenar  ||| S:1510 E:1517 ||| JJ
StO2  ||| S:1517 E:1522 ||| NN
and  ||| S:1522 E:1526 ||| CC
that  ||| S:1526 E:1531 ||| IN
the  ||| S:1531 E:1535 ||| DT
depth  ||| S:1535 E:1541 ||| NN
at  ||| S:1541 E:1544 ||| IN
which  ||| S:1544 E:1550 ||| WDT
StO2  ||| S:1550 E:1555 ||| NNP
is  ||| S:1555 E:1558 ||| VBZ
measured  ||| S:1558 E:1567 ||| VBN
is  ||| S:1567 E:1570 ||| VBZ
of  ||| S:1570 E:1573 ||| IN
minor  ||| S:1573 E:1579 ||| JJ
influence ||| S:1579 E:1588 ||| NN
.  ||| S:1588 E:1590 ||| .
Our  ||| S:1590 E:1594 ||| PRP$
data  ||| S:1594 E:1599 ||| NNS
support  ||| S:1599 E:1607 ||| VBP
the  ||| S:1607 E:1611 ||| DT
use  ||| S:1611 E:1615 ||| NN
of  ||| S:1615 E:1618 ||| IN
forearm  ||| S:1618 E:1626 ||| JJ
StO2  ||| S:1626 E:1631 ||| NN
as  ||| S:1631 E:1634 ||| IN
a  ||| S:1634 E:1636 ||| DT
sensitive  ||| S:1636 E:1646 ||| JJ
parameter  ||| S:1646 E:1656 ||| NN
for  ||| S:1656 E:1660 ||| IN
the  ||| S:1660 E:1664 ||| DT
detection  ||| S:1664 E:1674 ||| NN
of  ||| S:1674 E:1677 ||| IN
central  ||| S:1677 E:1685 ||| JJ
hypovolemia  ||| S:1685 E:1697 ||| NN
and  ||| S:1697 E:1701 ||| CC
hypovolemic  ||| S:1701 E:1713 ||| JJ
shock  ||| S:1713 E:1719 ||| NN
in  ||| S:1719 E:1722 ||| IN
( ||| S:1722 E:1723 ||| -LRB-
trauma ||| S:1723 E:1729 ||| LS
)  ||| S:1729 E:1731 ||| -RRB-
patients ||| S:1731 E:1739 ||| NNS
.  ||| S:1739 E:1741 ||| .
